Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Ischemic Heart Disease

  Free Subscription


3 Am Heart J
9 Am J Cardiol
1 Angiology
1 Ann Intern Med
3 Ann Thorac Surg
2 Arterioscler Thromb Vasc Biol
8 Atherosclerosis
1 Circ Cardiovasc Interv
1 Circ J
2 Circulation
2 Clin Cardiol
4 J Am Coll Cardiol
1 J Clin Endocrinol Metab
1 J Mol Cell Cardiol
5 J Thorac Cardiovasc Surg
1 Mol Cell Biochem
2 PLoS One
1 Thromb Haemost

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am Heart J

  1. BOHM F, Mogensen B, Ostlund O, Engstrom T, et al
    The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial.
    Am Heart J. 2021;241:92-100.
    PubMed         Abstract available

  2. DUCROCQ G, Bhatt DL, Lee JJ, Kui N, et al
    Balance of Benefit and Risk of Ticagrelor in Patients With Diabetes and Stable Coronary Artery Disease According to Bleeding Risk Assessment With the CRUSADE Score: Data From THEMIS and THEMIS PCI: Abbreviated title: Bleeding risk stratification of ti
    Am Heart J. 2022 Mar 20. pii: S0002-8703(22)00055.
    PubMed         Abstract available

  3. ERQOU S, Papaila A, Halladay C, Ge A, et al
    Variation in Statin Prescription among Veterans with HIV and Known Atherosclerotic Cardiovascular Disease.
    Am Heart J. 2022 Mar 19. pii: S0002-8703(22)00054.
    PubMed         Abstract available

    Am J Cardiol

  4. DOOLUB G, Kobo O, Mohamed MO, Ullah W, et al
    Outcomes of Percutaneous Coronary Intervention in Patients With Acquired Immunosuppression.
    Am J Cardiol. 2022 Mar 15. pii: S0002-9149(22)00113.
    PubMed         Abstract available

  5. VIJAY A, Kandula NR, Kanaya AM, Khan SS, et al
    Relation of Menopause With Cardiovascular Risk Factors in South Asian American Women (from the MASALA Study).
    Am J Cardiol. 2022 Mar 15. pii: S0002-9149(22)00129.
    PubMed         Abstract available

  6. CAI A, Qiu W, Xiao X, Xia S, et al
    All-Cause Mortality in Ischemic Heart Failure Patients with Functional Mitral Regurgitation Undergoing Percutaneous Coronary Intervention.
    Am J Cardiol. 2022 Mar 16. pii: S0002-9149(22)00112.
    PubMed         Abstract available

  7. AL RIFAI M, Vaughan EM, Abushamat LA, Lee M, et al
    Correlates of Glucagon-Like Peptide-1 Receptor Agonist Use Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes Mellitus (from the Department of Veterans Affairs).
    Am J Cardiol. 2022 Mar 16. pii: S0002-9149(22)00166.
    PubMed         Abstract available

  8. KUMAR R, Ammar A, Saghir T, Sial JA, et al
    Development and Validation of a Novel Risk Stratification Model for Slow-Flow/No-Reflow During Primary Percutaneous Coronary Intervention (the RK-SF/NR Score).
    Am J Cardiol. 2022 Mar 16. pii: S0002-9149(22)00110.
    PubMed         Abstract available

  9. OH M, Gabriel KP, Jacobs DR Jr, Bao W, et al
    Cardiorespiratory Fitness in Adults Aged 18 to 34 Years and Long-Term Pericardial Adipose Tissue (from the Coronary Artery Risk Development in Young Adults Study).
    Am J Cardiol. 2022 Mar 19. pii: S0002-9149(22)00186.
    PubMed         Abstract available

  10. GARCIA-GUIMARAES M, Fuertes-Ferre G, Jimenez-Valero S, Lozano I, et al
    Characteristics, Acute Results, and Prognostic Impact of Percutaneous Coronary Interventions in Spontaneous Coronary Artery Dissection (from the Prospective Spanish Registry on SCAD [SR-SCAD]).
    Am J Cardiol. 2022 Mar 20. pii: S0002-9149(22)00162.

  11. ESSA M, Ghajar A, Delago A, Hammond-Haley M, et al
    Demographic and State-Level Trends in Mortality Due to Ischemic Heart Disease in the United States from 1999 to 2019.
    Am J Cardiol. 2022 Mar 19. pii: S0002-9149(22)00165.
    PubMed         Abstract available

  12. CHANGAL K, Mir T, Royfman R, Devarasetty PP, et al
    Coronary Artery Aneurysms in ST-Elevation Myocardial Infarction (From a United States Based National Cohort).
    Am J Cardiol. 2022 Mar 20. pii: S0002-9149(22)00108.
    PubMed         Abstract available


  13. IIYA M, Hikita H, Yoshikawa H, Abe F, et al
    Impact of Hemodialysis Duration on Coronary Artery Calcification Among Hemodialysis Patients Who Underwent Percutaneous Coronary Intervention.
    Angiology. 2022 Mar 22:33197211073407. doi: 10.1177/00033197211073407.
    PubMed         Abstract available

    Ann Intern Med

  14. SEN A, Gemes K, Stalhammar G, Svensen C, et al
    Risk for Acute Myocardial Infarction After Ophthalmologic Procedures.
    Ann Intern Med. 2022 Mar 22. doi: 10.7326/M20-6618.
    PubMed         Abstract available

    Ann Thorac Surg

  15. LEE JH, Cho Y, Kim YJ, Cho YH, et al
    Impact of Individual Income Level on Late Mortality After Coronary Artery Bypass Grafting.
    Ann Thorac Surg. 2022 Mar 16. pii: S0003-4975(22)00340.
    PubMed         Abstract available

  16. RORRIS FP, Argiriou M
    The perpetual struggle for coronary revascularization.
    Ann Thorac Surg. 2022 Mar 19. pii: S0003-4975(22)00351.

    Lessons for Surgeons - Is Coronary Artery Endarterectomy Safe and Effective?
    Ann Thorac Surg. 2022 Mar 21. pii: S0003-4975(22)00362.

    Arterioscler Thromb Vasc Biol

  18. Correction to: Neutrophil-Derived Protein S100A8/A9 Alters the Platelet Proteome in Acute Myocardial Infarction and Is Associated With Changes in Platelet Reactivity.
    Arterioscler Thromb Vasc Biol. 2022;42:e115.

  19. BONGIOVANNI D, Han J, Klug M, Kirmes K, et al
    Role of Reticulated Platelets in Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2022 Mar 24:ATVBAHA121316244.
    PubMed         Abstract available


  20. YOSHIDA Y, Chen Z, Baudier RL, Krousel-Wood M, et al
    Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.
    Atherosclerosis. 2022;344:13-19.
    PubMed         Abstract available

  21. FUJIMOTO D, Otake H, Kawamori H, Toba T, et al
    Cholesterol uptake capacity: A new measure of high-density lipoprotein functionality as a predictor of subsequent revascularization in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2022;345:44-50.
    PubMed         Abstract available

  22. KOSHY AN, Nerlekar N, Gow PJ, Lim R, et al
    A prospective natural history study of coronary atherosclerosis following liver transplantation.
    Atherosclerosis. 2022;344:40-48.
    PubMed         Abstract available

  23. KOBO O, Saada M, Laanmets P, Karageorgiev D, et al
    Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry.
    Atherosclerosis. 2022;344:71-77.
    PubMed         Abstract available

  24. ASZTALOS BF, Hauser TH, Goldfine AB, Welty FK, et al
    The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
    Atherosclerosis. 2022;345:1-6.
    PubMed         Abstract available

  25. BAJAJ R, Eggermont J, Grainger SJ, Raber L, et al
    Machine learning for atherosclerotic tissue component classification in combined near-infrared spectroscopy intravascular ultrasound imaging: Validation against histology.
    Atherosclerosis. 2022;345:15-25.
    PubMed         Abstract available

  26. HE X, Dong B, Liang W, Wu Y, et al
    Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
    Atherosclerosis. 2022;344:1-6.
    PubMed         Abstract available

  27. KUNIO M, Gardecki JA, Watanabe K, Nishimiya K, et al
    Histopathological correlation of near infrared autofluorescence in human cadaver coronary arteries.
    Atherosclerosis. 2022;344:31-39.
    PubMed         Abstract available


  28. HODKINSON A, Tsimpida D, Kontopantelis E, Rutter MK, et al
    Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis.
    BMJ. 2022;376:e067731.
    PubMed         Abstract available

    Circ Cardiovasc Interv

  29. HAN Y, Claessen BE, Chen SL, Chunguang Q, et al
    Ticagrelor With or Without Aspirin in Chinese Patients Undergoing Percutaneous Coronary Intervention: A TWILIGHT China Substudy.
    Circ Cardiovasc Interv. 2022 Mar 23:CIRCINTERVENTIONS120009495.
    PubMed         Abstract available

    Circ J

  30. HANADA K, Sasaki S, Seno M, Kimura Y, et al
    Reduced Left Ventricular Ejection Fraction Is a Risk for Sudden Cardiac Death in the Early Period After Hospital Discharge in Patients With Acute Myocardial Infarction.
    Circ J. 2022 Mar 18. doi: 10.1253/circj.CJ-21-0999.
    PubMed         Abstract available


  31. NG CF, Teoh JYC, Chiu PKF
    Letter by Ng et al Regarding Article, "Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial".
    Circulation. 2022;145:e773-e774.

  32. Correction to: Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
    Circulation. 2022;145:e775.

    Clin Cardiol

  33. SUN M, Xing Y, Guo Y, Cao X, et al
    Left atrial reservoir strain is an outstanding predictor of adverse cardiovascular outcomes in patients undergoing maintenance hemodialysis: Assessment via three-dimensional speckle tracking echocardiography.
    Clin Cardiol. 2022 Mar 21. doi: 10.1002/clc.23815.
    PubMed         Abstract available

  34. STOHR R, Dirrichs T, Kneizeh K, Reinartz S, et al
    Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism.
    Clin Cardiol. 2022 Mar 25. doi: 10.1002/clc.23819.
    PubMed         Abstract available

    J Am Coll Cardiol

  35. POWER DA, Lampert J, Camaj A, Bienstock SW, et al
    Cardiovascular Complications of Interatrial Conduction Block: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:1199-1211.
    PubMed         Abstract available

    The Cardiovascular Pharmaceutical Cornucopia: A Conundrum of Riches.
    J Am Coll Cardiol. 2022;79:1138-1140.

  37. DOUGLAS PS, Mack MJ, Acosta DA, Benjamin EJ, et al
    2022 ACC Health Policy Statement on Building Respect, Civility, and Inclusion in the Cardiovascular Workplace: A Report of the American College of Cardiology Solution Set Oversight Committee.
    J Am Coll Cardiol. 2022 Mar 12. pii: S0735-1097(22)00585.

  38. GLUCKMAN TJ, Bhave NM, Allen LA, Chung EH, et al
    2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology
    J Am Coll Cardiol. 2022 Mar 14. pii: S0735-1097(22)00306.

    J Clin Endocrinol Metab

  39. DAM V, Onland-Moret NC, Burgess S, Chirlaque MD, et al
    Genetically determined reproductive aging and coronary heart disease: a bidirectional two-sample Mendelian Randomization.
    J Clin Endocrinol Metab. 2022 Mar 20. pii: 6550950. doi: 10.1210.
    PubMed         Abstract available

    J Mol Cell Cardiol

  40. WANG YL, Bai L, Shi XR, Zhu H, et al
    Osteoblast MR deficiency protects against adverse ventricular remodeling after myocardial infarction.
    J Mol Cell Cardiol. 2022 Mar 18. pii: S0022-2828(22)00047.
    PubMed         Abstract available

    J Thorac Cardiovasc Surg

  41. KASHIYAMA N, Kormos RL, Matsumura Y, D'Amore A, et al
    Adipose-derived stem cell sheet under an elastic patch improves cardiac function in rats after myocardial infarction.
    J Thorac Cardiovasc Surg. 2022;163:e261-e272.
    PubMed         Abstract available

  42. WANG M, Yan L, Li Q, Yang Y, et al
    Mesenchymal stem cell secretions improve donor heart function following ex vivo cold storage.
    J Thorac Cardiovasc Surg. 2022;163:e277-e292.
    PubMed         Abstract available

  43. KIM MS, Hwang HY, Cho KR, Kim KB, et al
    Right gastroepiploic artery versus right internal thoracic artery composite grafts: 10-year patency and long-term outcomes.
    J Thorac Cardiovasc Surg. 2022;163:1333-1343.
    PubMed         Abstract available

  44. SANO T, Ito T, Ishigami S, Bandaru S, et al
    Intrinsic activation of cardiosphere-derived cells enhances myocardial repair.
    J Thorac Cardiovasc Surg. 2022;163:1479-1490.
    PubMed         Abstract available

  45. BARAC YD, Witberg G, Assali A, Klempfner R, et al
    The Clinical SYNTAX score predicts survival better than the SYNTAX score in coronary revascularization.
    J Thorac Cardiovasc Surg. 2022 Feb 24. pii: S0022-5223(22)00217.
    PubMed         Abstract available


  46. BRUXVOORT K, Slezak J, Qian L, Sy LS, et al
    Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
    JAMA. 2022 Mar 25. pii: 2790492. doi: 10.1001/jama.2022.2540.
    PubMed         Abstract available

    Mol Cell Biochem

  47. THAKKAR H, Vincent V, Roy A, Gautam AK, et al
    Determinants of high-density lipoprotein (HDL) functions beyond proteome in Asian Indians: exploring the fatty acid profile of HDL phospholipids.
    Mol Cell Biochem. 2022;477:559-570.
    PubMed         Abstract available

    PLoS One

  48. YAMADA Y, Minatoguchi S, Baba S, Shibata S, et al
    Human Muse cells reduce myocardial infarct size and improve cardiac function without causing arrythmias in a swine model of acute myocardial infarction.
    PLoS One. 2022;17:e0265347.
    PubMed         Abstract available

  49. MURUGIAH K, Chen L, Dreyer RP, Bouras G, et al
    Health status outcomes after spontaneous coronary artery dissection and comparison with other acute myocardial infarction: The VIRGO experience.
    PLoS One. 2022;17:e0265624.
    PubMed         Abstract available

    Thromb Haemost

  50. MALY M, Riedel T, Stikarova J, Suttnar J, et al
    Incorporation of Fibrin, Platelets, and Red Blood Cells into a Coronary Thrombus in Time and Space.
    Thromb Haemost. 2022;122:434-444.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.